In the United States, there is clear evidence that minority populations continue to be underrepresented in clinical research related to new therapies for common and serious long-term medical conditions such as type 2 diabetes (T2D). This is despite these same populations facing a continuing and disproportionate burden of T2D, which shows no signs of abating.
Black people have one of the highest rates of T2D (13.2 percent), a rate almost twice ...
Read more...
![\"Quantcast\"/](\"//pixel.quantserve.com/pixel/p-9b8RJMzccQ21I.gif\")
Past 6 Months
Should nurse practitioners complete medical residencies?
Anonymous | PhysicianWhat’s the future of the physician assistant?
Dale J. Bingham, PA-C, MPH | PolicyA physician’s experience of bigotry in medicine
K. C. Ardem, MD | PhysicianI’m a doctor in a family of COVID deniers
Nicholas Stark, MD, MBA | PhysicianHow MOC is contributing to the demise of physicians
Torie S. Sepah, MD | PhysicianA COVID-19 coronavirus update from concerned physicians
Howard J. Luks, MD, Joel Topf, MD, Ethan J. Weiss, MD, Carrie Diulus, MD, Nancy Yen Shipley, MD, and Dr. Eric Levi | Conditions